US90184D1000
US90184D1000
Twist Bioscience Corporation
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 60/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±78.2% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.2x as much as the broader market.
Beta (Market Relation)
2.19x
Above averageVolatility (5Y p.a.)
78.2% p.a.
5-Year HorizonMax Drawdown (5Y)
-91.5%
5-Year HorizonSharpe Ratio
0.08
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +363.7% |
| 3 Years | 73.9% | -59.0% | 1.34 | +101.8% |
| 5 Years | 78.2% | -91.5% | 0.08 | +9.1% |
| 10 Years | 79.1% | -94.5% | 0.41 | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 2.19 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (78.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -94.5% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
8 ISS Score: 8 / 10
Audit Risk
1 ISS Score: 1 / 10
Board Risk
7 ISS Score: 7 / 10
Short Ratio
7.74